Medical Marijuana Workshop - Part 2/3 (Audio)

The cannabis industry functions as a potent catalyst for political and societal change. Business development within the medical marijuana sector is framed as a crucial mechanism for ending prohibition, as entrepreneurs and investors create legitimate, profitable, and politically engaged enterprises that normalize cannabis use and promote responsible regulation. Mimi Peleg describes the development of medical cannabis frameworks in Israel, emphasizing a research-friendly environment where government cooperation facilitates clinical trials and patient access. The national healthcare system allows for longitudinal data collection, which is used to refine treatment protocols. Alan Shackelford highlights the efficacy of cannabis in treating various conditions and outlines the complex, often restrictive regulatory barriers to conducting rigorous clinical research in the United States, contrasted with the more supportive Israeli infrastructure.